日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity

青蒿素靶向GABAA受体信号传导并损害α细胞特性

Jin Li ,Tamara Casteels ,Thomas Frogne ,Camilla Ingvorsen ,Christian Honoré ,Monica Courtney ,Kilian V M Huber ,Nicole Schmitner ,Robin A Kimmel ,Roman A Romanov ,Caterina Sturtzel ,Charles-Hugues Lardeau ,Johanna Klughammer ,Matthias Farlik ,Sara Sdelci ,Andhira Vieira ,Fabio Avolio ,François Briand ,Igor Baburin ,Peter Májek ,Florian M Pauler ,Thomas Penz ,Alexey Stukalov ,Manuela Gridling ,Katja Parapatics ,Charlotte Barbieux ,Ekaterine Berishvili ,Andreas Spittler ,Jacques Colinge ,Keiryn L Bennett ,Steffen Hering ,Thierry Sulpice ,Christoph Bock ,Martin Distel ,Tibor Harkany ,Dirk Meyer ,Giulio Superti-Furga ,Patrick Collombat ,Jacob Hecksher-Sørensen ,Stefan Kubicek

Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth

米哚妥林及其代谢物在肿瘤性肥大细胞中的靶点相互作用分析预测了其对细胞活化和生长的不同影响

Peter, B; Winter, G E; Blatt, K; Bennett, K L; Stefanzl, G; Rix, U; Eisenwort, G; Hadzijusufovic, E; Gridling, M; Dutreix, C; Hoermann, G; Schwaab, J; Radia, D; Roesel, J; Manley, P W; Reiter, A; Superti-Furga, G; Valent, P

A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis

细胞筛选鉴定出帕纳替尼和帕唑帕尼为坏死凋亡抑制剂

A Fauster, M Rebsamen, K V M Huber, J W Bigenzahn, A Stukalov, C-H Lardeau, S Scorzoni, M Bruckner, M Gridling, K Parapatics, J Colinge, K L Bennett, S Kubicek, S Krautwald, A Linkermann, G Superti-Furga

Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action

利用化学蛋白质组学对抗转移药物RAPTA进行靶点分析:与作用机制的相关性

Babak, Maria V; Meier, Samuel M; Huber, Kilian V M; Reynisson, Jóhannes; Legin, Anton A; Jakupec, Michael A; Roller, Alexander; Stukalov, Alexey; Gridling, Manuela; Bennett, Keiryn L; Colinge, Jacques; Berger, Walter; Dyson, Paul J; Superti-Furga, Giulio; Keppler, Bernhard K; Hartinger, Christian G

Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy

(S)-克唑替尼立体定向靶向 MTH1 作为抗癌策略

Kilian V M Huber, Eidarus Salah, Branka Radic, Manuela Gridling, Jonathan M Elkins, Alexey Stukalov, Ann-Sofie Jemth, Camilla Göktürk, Kumar Sanjiv, Kia Strömberg, Therese Pham, Ulrika Warpman Berglund, Jacques Colinge, Keiryn L Bennett, Joanna I Loizou, Thomas Helleday, Stefan Knapp, Giulio Superti

The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity

溶质载体SLC35F2使YM155介导的DNA损伤毒性

Georg E Winter, Branka Radic #, Cristina Mayor-Ruiz #, Vincent A Blomen, Claudia Trefzer, Richard K Kandasamy, Kilian V M Huber, Manuela Gridling, Doris Chen, Thorsten Klampfl, Robert Kralovics, Stefan Kubicek, Oscar Fernandez-Capetillo, Thijn R Brummelkamp, Giulio Superti-Furga

A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF

化学生物学方法确定 AMPK 是黑色素瘤致癌基因 MITF 的调节剂

V Borgdorff, U Rix, G E Winter, M Gridling, A C Müller, F P Breitwieser, C Wagner, J Colinge, K L Bennett, G Superti-Furga, S N Wagner

Identification of kinase inhibitor targets in the lung cancer microenvironment by chemical and phosphoproteomics

利用化学和磷酸化蛋白质组学方法鉴定肺癌微环境中的激酶抑制剂靶点

Gridling, Manuela; Ficarro, Scott B; Breitwieser, Florian P; Song, Lanxi; Parapatics, Katja; Colinge, Jacques; Haura, Eric B; Marto, Jarrod A; Superti-Furga, Giulio; Bennett, Keiryn L; Rix, Uwe

A miniaturized chemical proteomic approach for target profiling of clinical kinase inhibitors in tumor biopsies

一种用于肿瘤活检中临床激酶抑制剂靶向分析的微型化学蛋白质组学方法

Ivo Chamrád, Uwe Rix, Alexey Stukalov, Manuela Gridling, Katja Parapatics, André C Müller, Soner Altiok, Jacques Colinge, Giulio Superti-Furga, Eric B Haura, Keiryn L Bennett

Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML

系统药理学剖析伊马替尼耐药慢性粒细胞白血病的药物协同作用

Georg E Winter #, Uwe Rix #, Scott M Carlson, Karoline V Gleixner, Florian Grebien, Manuela Gridling, André C Müller, Florian P Breitwieser, Martin Bilban, Jacques Colinge, Peter Valent, Keiryn L Bennett, Forest M White, Giulio Superti-Furga